You have 9 free searches left this month | for more free features.

Selective Serotonin Reuptake Inhibitor

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Depression, Serotonin Deficiency Trial in Kelowna (Pharmacological agent: Citalopram, Placebo)

Not yet recruiting
  • Depression
  • Serotonin Deficiency
  • Pharmacological agent: Citalopram
  • Placebo
  • Kelowna, British Columbia, Canada
    University of British Columbia, Okanagan Campus
Jul 19, 2023

Neurodevelopmental Disorders, Autism, Autism Spectrum Disorder Trial in Canada (Sertraline, Placebo)

Not yet recruiting
  • Neurodevelopmental Disorders
  • +25 more
  • Calgary, Alberta, Canada
  • +6 more
Oct 11, 2023

Chest Pain Rule Out Myocardial Infarction Trial in Athens (Citalopram)

Terminated
  • Chest Pain Rule Out Myocardial Infarction
  • Athens, Attiki, Greece
    Evangelismos Hospital
Nov 27, 2019

Meniere Disease Trial in Charleston (Venlafaxine, Placebo oral tablet)

Recruiting
  • Meniere Disease
  • Charleston, South Carolina
    Medical Univeristy of South Carolina
Dec 2, 2021

DaTSCAN Brain Scintigraphy and Psychotropic Treatments:

Not yet recruiting
  • Parkinson Disease
  • scintigraphy DaTSCAN
  • Vandœuvre-lès-Nancy, France
    CHRU Nancy
Jan 5, 2023

Depression, Parkinson Disease Trial (Nortriptyline, Escitalopram, Placebo)

Recruiting
  • Depression
  • Parkinson Disease
  • London, United Kingdom
    Royal Free London NHS Foundation Trust
Nov 2, 2022

Post-Traumatic Stress Disorder Trial (Nabiximols, Placebo)

Withdrawn
  • Post-Traumatic Stress Disorder
  • (no location specified)
Jun 2, 2022

OCD Trial in Dhaka (N-acetylcysteine tablet 600mg, Placebo tablet 600mg)

Recruiting
  • OCD
  • N-acetylcysteine tablet 600mg
  • Placebo tablet 600mg
  • Dhaka, Bangladesh
  • +1 more
Nov 14, 2021

Obesity, Depression Trial in Lucerne (Roux-en-Y gastric bypass, sleeve gastrectomy)

Completed
  • Obesity
  • Depression
  • Roux-en-Y gastric bypass, sleeve gastrectomy
  • Lucerne, Switzerland
    Luzerner Kantonsspital
Jun 9, 2021

Depressive Disorder, Major Trial in Worldwide (Esketamine, SSRI/SNRI)

Active, not recruiting
  • Depressive Disorder, Major
  • Ciudad Autonoma de Buenos Aires, Argentina
  • +58 more
Jan 31, 2023

None (i.e. Healthy Volunteers) Trial in Ottawa (Levomilnacipran, Duloxetine, Placebos)

Active, not recruiting
  • None (i.e. Healthy Volunteers)
  • Ottawa, Ontario, Canada
    Institute of Mental Health Research, Royal Ottawa Mental Health
Oct 5, 2021

Generalized Anxiety Disorder Trial in Kingston (SSRIs/SNRIs (Selective Serotonin Reuptake Inhibitors/ Serotonin and

Completed
  • Generalized Anxiety Disorder
  • SSRIs/SNRIs (Selective Serotonin Reuptake Inhibitors/ Serotonin and Norepinephrine Reuptake Inhibitors)
  • Electronic Cognitive Behavioural Therapy
  • Kingston, Ontario, Canada
    Hotel Dieu Hospital
Sep 7, 2021

Healthy Trial in Shanghai (HEC113995PA•H2O tablet, Placebo tablet)

Completed
  • Healthy
  • HEC113995PA•H2O tablet
  • Placebo tablet
  • Shanghai, Shanghai, China
    The Shanghai xuhui district central hospital
May 11, 2021

MDD Trial in Bhubaneswar (Selective Serotonin Reuptake Inhibitors, Dextromethorphan, Placebo)

Recruiting
  • Major Depressive Disorder
  • Selective Serotonin Reuptake Inhibitors
  • +2 more
  • Bhubaneswar, Odisha, India
    All India Institute of Medical Sciences (AIIMS)
Feb 11, 2022

MDD Trial in Hangzhou (SSRI, SIA, AIA)

Recruiting
  • Major Depressive Disorder
  • Hangzhou, Zhejiang, China
    the Third affiliated hospital of Zhejiang Chinese Medical univer
Jan 31, 2023

Antidepressants in Advance of Investigational Trials

Recruiting
  • Major Depressive Disorder
  • FDA-approved selective-serotonin reuptake inhibitors (SSRIs) and selective-norepinephrine reuptake inhibitors (SNRIs)
  • Watertown, Massachusetts
    Adams Clinical
Mar 9, 2021

Depression, MDD, Mild Depression Trial in Abbotsford (Psilocybin)

Not yet recruiting
  • Depression
  • +4 more
  • Abbotsford, British Columbia, Canada
    Centre for Neurology Studies x Upstream
Oct 25, 2022

Anxiety Disorder, Insomnia Trial in Changxing, Linping, Yiwu (Pulse magnetic therapy, Selective serotonin reuptake inhibitors

Recruiting
  • Anxiety Disorder
  • Insomnia
  • Pulse magnetic therapy
  • +2 more
  • Changxing, Zhejiang, China
  • +2 more
Jan 30, 2023

Following Menopause Treated WithNon-hormonal Therapy for Hot

Not yet recruiting
  • Hot Flashes
  • (no location specified)
Sep 18, 2023

MDD, Recurrent, Unspecified, MDD, Single Episode, Unspecified Trial in Worldwide (H-Coil Deep TMS in combination with SSRIs)

Completed
  • Major Depressive Disorder, Recurrent, Unspecified
  • Major Depressive Disorder, Single Episode, Unspecified
  • H-Coil Deep TMS in combination with SSRIs
  • Davis, California
  • +18 more
Jul 13, 2020

Depressive Disorder, Major, Anhedonia Trial in Worldwide (Aticaprant, Placebo)

Recruiting
  • Depressive Disorder, Major
  • Anhedonia
  • Birmingham, Alabama
  • +156 more
Jan 31, 2023

Tibial Plateau Fracture, Pain, Postoperative Trial in Boston, Valhalla (Duloxetine, Placebo, Standard of care (SOC) for tibial

Not yet recruiting
  • Tibial Plateau Fracture
  • Pain, Postoperative
  • Boston, Massachusetts
  • +1 more
Aug 6, 2022

Depressive Disorder, Major, Anhedonia Trial in Worldwide (Aticrapant, Placebo)

Recruiting
  • Depressive Disorder, Major
  • Anhedonia
  • Phoenix, Arizona
  • +72 more
Jul 10, 2022

Depression, MDD, Dysthymic Disorder Trial in Indianapolis (behavioral, drug, other)

Recruiting
  • Depression
  • +6 more
  • Good Days Ahead (GDA)
  • +3 more
  • Indianapolis, Indiana
    IUPUI Department of Psychology
Jan 18, 2022

Antidepressants in Advance of Investigational Trials, Relapse

Recruiting
  • Major Depressive Disorder
  • FDA-approved selective-serotonin reuptake inhibitors (SSRIs) and selective-norepinephrine reuptake inhibitors (SNRIs)
  • Watertown, Massachusetts
    Adams Clinical
Jun 14, 2021